<DOC>
	<DOCNO>NCT02448407</DOCNO>
	<brief_summary>Platelet-rich plasma ( PRP ) , due high content cytokine , bioactive protein platelet growth factor , may contribute diminish pain arthritic knee . It also recently recognize regenerative cell potential improve concentration hyaluronic acid stabilize angiogenesis arthritic knee This study therefore seek ass analgesic power PRP osteoarthritic knee intraarticularly infiltrate , patient would benefit treatment , eliminate false expectation rest .</brief_summary>
	<brief_title>Intraarticular Injections Platelet-rich Plasma Pain 's Treatment Osteoarthritic Knee</brief_title>
	<detailed_description>This first clinical trial develop follow report Spanish Competent Authority May 23 , 2013 , consider PRP medicinal product human use establish minimum guarantee require product process manufacturing . It conduct perspective trauma specialize treatment chronic pain anesthesiologist , manufacture PRP premise Regional Centre Transfusions , belong Public Health System therefore without commercial interest .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Arthritis knee rat I , II , III ( KellgrenLawrence Grading Scale ) VAS great 5 Between 40and 80 year age Level IV arthritis knee Either surgery , corticoid infiltration , viscosupplementation knee previous three month Frontal deformity great 10 degree Ipsilateral pathology knee ankle Range motion flexibility knee le 90 degree Deficit knee extension great 15 degree Anticoagulation treatment , antiplatelet treatment Hepatopathy Hematological neoplastic pathology Active infection Fibromyalgia Chronic fatigue syndrome</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Knee osteoarthritis</keyword>
	<keyword>Platelet-rich plasma</keyword>
	<keyword>Pain 's treatment</keyword>
</DOC>